Clinical Evidence

Acne-induced Post-inflammatory Hyperpigmentation

Diethylhexyl Syringylidenemalonate has been studied for its role in managing acne-induced post-inflammatory hyperpigmentation (AI-PIH). This condition can occur even in mild cases of acne, and effective treatment options are essential. The study provides a grading tool for AI-PIH severity and treatment recommendations. For more details, see Acne-induced Post-inflammatory Hyperpigmentation: From Grading to Treatment.

Prevention of Post-inflammatory Hyperpigmentation

A randomized trial evaluated a broad-spectrum sunscreen containing Diethylhexyl Syringylidenemalonate for preventing PIH in skin of color. The results showed significant protection against pigmentation changes, highlighting its potential in skincare formulations. For further insights, refer to An Investigator-Blinded, Randomized Trial of a Broad-Spectrum Sunscreen.

Photoprotection for Skin of Color

The importance of adequate photoprotection, especially for skin of color, is emphasized in the literature. Diethylhexyl Syringylidenemalonate may play a role in formulations that address the unique needs of this demographic. For more information, check Availability of Adequate Photoprotection for Skin of Color.